Identification of insulin secretory defects and insulin resistance during oral glucose tolerance test in a cohort of cystic fibrosis patients

European Journal of Endocrinology

Volumn 165, Issue 1, 2011, Pages 69-76

  Battezzati, A ^a   Mari, A ^b   Zazzeron, L ^a   Alicandro, G ^a   Claut, L ^a   Battezzati, P M ^a   Colombo, C ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; GLUCOSE; INSULIN;

ADOLESCENT; ADULT; AGE; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CYSTIC FIBROSIS; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE; HUMAN; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; CELL FUNCTION; CONCENTRATION (PARAMETERS); GLUCOSE TOLERANCE TEST; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; SECRETION;

ADOLESCENT; ADULT; C-PEPTIDE; CYSTIC FIBROSIS; DIABETES MELLITUS; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; INSULIN RESISTANCE; MALE;

EID: 79959438295     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-10-1003     Document Type: Article

References (59)

1. Cystic Fibrosis Foundation Patient Registry. 2008 Annual Data Report Bethesda, MD, 2009 Cystic Fibrosis Foundation.
2. Lanng S, Hansen A, Thorsteinsson B, Nerup J & Koch C. Glucose tolerance in patients with cystic fibrosis: five-year prospective study. BMJ 1995 311 655-659.
3. Finkelstein SM, Wielinski CL, Elliott GR, Warwick WJ, Barbosa J, Wu SC & Klein DJ. Diabetes mellitus associated with cystic fibrosis. Journal of Pediatrics 1988 112 373-377. (doi:10.1016/S0022-3476(88)80315-9)
4. Lanng S, Thorsteinsson B, Nerup J & Koch C. Influence of the development of diabetes mellitus on clinical status in patients with cystic fibrosis. European Journal of Pediatrics 1992 151 684-687. (doi:10.1007/ BF01957574)
5. Lanng S, Thorsteinsson B, Nerup J & Koch C. Diabetes mellitus in cystic fibrosis: effect of insulin therapy on lung function and infections. Acta Paediatrica 1994 83 849-853. (doi:10.1111/j.1651-2227.1994.tb13156.x)
6. Milla CE, Warwick WJ & Moran A. Trends in pulmonary function in patients with cystic fibrosis correlate with the degree of glucose intolerance at baseline. American Journal of Respiratory and Critical Care Medicine 2000 162 891-895.
7. Marshall BC, Butler SM, Stoddard M, Moran AM, Liou TG & Morgan WJ. Epidemiology of cystic fibrosis-related diabetes. Journal of Pediatrics 2005 146 681-687. (doi:10.1016/j.jpeds.2004.12.039)
8. Bismuth E, Laborde K, Taupin P, Velho G, Ribault V, Jennane F, Grasset E, Sermet I, de Blic J, Lenoir G & Robert JJ. Glucose tolerance and insulin secretion, morbidity, and death in patients with cystic fibrosis. Journal of Pediatrics 2008 152 540-545. (doi:10.1016/j.jpeds.2007.09.025)
9. Chamnan P, Shine BS, Haworth CS, Bilton D & Adler AI. Diabetes as a determinant of mortality in cystic fibrosis. Diabetes Care 2010 33 311-316. (doi:10.2337/dc09-1215)
10. Hameed S, Morton JR, Jaffé A, Field PI, Belessis Y, Yoong T, Katz T & Verge CF. Early glucose abnormalities in cystic fibrosis are preceded by poor weight gain. Diabetes Care 2010 33 221-226. (doi:10.2337/dc09-1492)
11. Costa M, Potvin S, Hammana I, Malet A, Berthiaume Y, Jeanneret A, Lavoie A, Ĺ vesque R, Perrier J, Poisson D, Karelis AD, Chiasson JL & Rabasa-Lhoret R. Increased glucose excursion in cystic fibrosis and its association with a worse clinical status. Journal of Cystic Fibrosis 2007 6 376-383. (doi:10.1016/j.jcf.2007.02.005)
12. Jefferies C, Solomon M, Perlman K, Sweezey N & Daneman D. Continuous glucose monitoring in adolescents with cystic fibrosis. Journal of Pediatrics 2005 147 396-398. (doi:10.1016/j.jpeds.2005.05.004)
13. Lanng S, Thorsteinsson B, Erichsen G, Nerup J & Koch C. Glucose tolerance in cystic fibrosis. Archives of Disease in Childhood 1991 66 612-616. (doi:10.1136/adc.66.5.612)
14. Battezzati A, Battezzati PM, Costantini D, Seia M, Zazzeron L, Russo MC, Daccò V, Bertoli S, Crosignani A & Colombo C. Spontaneous hypoglycemia in patients with cystic fibrosis. European Journal of Endocrinology 2007 156 369-376. (doi:10.1530/eje.1.02344)
15. Moran A, Hardin D, Rodman D, Allen HF, Beall RJ, Borowitz D, Brunzell C, Campbell PW, Chesrown SE, Duchow C, Fink RJ, FitzSimmons SC, Hamilton N, Hirsch I, Howenstine MS, Klein DJ, Madhun Z, Pencharz PB, Quittner AL, Robbins MK, Schindler T, Schissel K, Schwarzenberg SJ, Stallings VA, Tullis DE & Zipf WB. Diagnosis, screening, and management of CFRD: a consensus conference report. Diabetes Research and Clinical Practice 1999 45 55-71. (doi:10.1016/S0168- 8227(99)00058-3)
16. O'Riordan SM, Dattani MT & Hindmarsh PC. Cystic fibrosis-related diabetes in childhood. Hormone Research in Paediatrics 2010 73 15-24. (doi:10.1159/000271912)
17. Brennan AL, Gyi KM, Wood DM, Hodson ME, Geddes DM & Baker EH. Relationship between glycosylated haemoglobin and mean plasma glucose concentration in cystic fibrosis. Journal of Cystic Fibrosis 2006 5 27-31.
18. Dobson L, Sheldon CD & Hattersley AT. Conventional measures underestimate glycaemia in cystic fibrosis patients. Diabetic Medicine 2004 21 691-696. (doi:10.1111/j.1464-5491.2004.01219.x)
19. Bennett PH, Burch TA & Miller M. Diabetes mellitus in American (Pima) Indians. Lancet 1971 2 125-128. (doi:10.1016/S0140-6736(71)92303-8)
20. Dobson L, Sheldon CD & Hattersley AT. Understanding cystic-fibrosis-related diabetes: best thought of as insulin deficiency? Journal of the Royal Society of Medicine 2004 97 26-35. (doi:10.1258/jrsm.97.1.26)
21. O'Riordan SM, Robinson PD, Donaghue KC, Moran A & the ISPAD Clinical Practice Consensus. Management of cystic fibrosis related diabetes. Pediatric Diabetes 2008 9 338-344. (doi:10.1111/j.1399-5448.2008.00437.x)
22. Hardin DS, Leblanc A, Marshall G & Seilheimer DK. Mechanisms of insulin resistance in cystic fibrosis. American Journal of Physiology. Endocrinology and Metabolism 2001 281 1022-1028.
23. Moran A, Diem P, Klein DJ, Levitt MD & Robertson RP. Pancreatic endocrine function in cystic fibrosis. Journal of Pediatrics 1991 118 715-723. (doi:10.1016/S0022-3476(05)80032-0)
24. Ahmad T, Nelson R & Taylor R. Insulin sensitivity and metabolic clearance rate of insulin in cystic fibrosis. Metabolism 1994 43 163-167. (doi:10.1016/0026-0495(94)90239-9)
25. Lanng S, Thorsteinsson B, Røder ME, Nerup J & Koch C. Insulin sensitivity and insulin clearance in cystic fibrosis patients with normal and diabetic glucose tolerance. Clinical Endocrinology 1994 41 217-223. (doi:10.1111/j.1365-2265.1994.tb02533.x)
26. Cucinotta D, Conti Nibali S, Arrigo T, Di Benedetto A, Magazzù G, Di Cesare E, Costantino A, Pezzino V & De Luca F. Beta cell function, peripheral sensitivity to insulin and islet cell autoimmunity in cystic fibrosis patients with normal glucose tolerance. Hormone Research 1990 34 33-38. (doi:10.1159/000181792)
27. Cucinotta D, De Luca F, Gigante A, Arrigo T, Di Benedetto A, Tedeschi A, Lombardo F, Romano G & Sferlazzas C. No changes of insulin sensitivity in cystic fibrosis patients with different degrees of glucose tolerance: an epidemiological and longitudinal study. European Journal of Endocrinology 1994 130 253-258. (doi:10.1530/eje.0.1300253)
28. Austin A, Kalhan SC, Orenstein D, Nixon P & Arslanian S. Roles of insulin resistance and beta-cell dysfunction in the pathogenesis of glucose intolerance in cystic fibrosis. Journal of Clinical Endocrinology and Metabolism 1994 79 80-85. (doi:10.1210/jc.79.1.80)
29. Moran A, Pyzdrowski KL, Weinreb J, Kahn BB, Smith SA, Adams KS & Seaquist ER. Insulin sensitivity in cystic fibrosis. Diabetes 1994 43 1020-1026. (doi:10.2337/diabetes.43.8.1020)
30. Hardin DS, LeBlanc A, Lukenbough S & Seilheimer DK. Insulin resistance is associated with decreased clinical status in cystic fibrosis. Journal of Pediatrics 1997 130 948-956. (doi:10.1016/S0022-3476(97)70282-8)
31. Hardin DS, LeBlanc A, Lukenbaugh S, Para L & Seilheimer DK. Proteolysis associated with insulin resistance in cystic fibrosis. Pediatrics 1998 101 433-437. (doi:10.1542/peds.101.3.433)
32. Moran A, Milla C, Ducret R & Nair KS. Protein metabolism in clinically stable adult cystic fibrosis patients with abnormal glucose tolerance. Diabetes 2001 50 1336-1343. (doi:10.2337/diabetes.50.6.1336)
33. Moran A, Basu R, Milla C & Jensen MD. Insulin regulation of free fatty acid kinetics in adult cystic fibrosis patients with impaired glucose tolerance. Metabolism 2004 53 1467-1472. (doi:10.1016/j.metabol.2004.06.015)
34. Hardin DS, LeBlanc A, Para L & Seilheimer DK. Hepatic insulin resistance and defects in substrate utilization in cystic fibrosis. Diabetes 1999 48 1082-1087. (doi:10.2337/diabetes.48.5.1082)
35. Hardin DS, Ahn C, Rice J, Rice M & Rosenblatt R. Elevated gluconeogenesis and lack of suppression by insulin contribute to cystic fibrosis-related diabetes. Journal of Investigative Medicine 2008 56 567-573. (doi:10.231/JIM.0b013e3181671788)
36. Wilmshurst EG, Soeldner JS, Holsclaw DS, Kaufmann RL, Shwachman H, Aoki TT & Gleason RE. Endogenous and exogenous insulin responses in patients with cystic fibrosis. Pediatrics 1975 55 75-82.
37. Yung B, Noormohamed FH, Kemp M, Hooper J, Lant AF & Hodson ME. Cystic fibrosis-related diabetes: the role of peripheral insulin resistance and beta-cell dysfunction. Diabetic Medicine 2002 19 221-226. (doi:10.1046/j.1464- 5491.2002.00666.x)
38. Preumont V, Lebecque P, Hermans MP & Buysschaert M. Glucose homeostasis and genotype-phenotype interplay in cystic fibrosis patients with CFTR gene DF508 mutation. Diabetes Care 2007 30 1187-1192. (doi:10.2337/dc06- 1915)
39. Tofe S, Moreno JC, Maiz L, Alonso M, Escobar H & Barrio R. Insulin secretion abnormalities and clinical deterioration related to impaired glucose tolerance in cystic fibrosis. European Journal of Endocrinology 2005 152 241-247. (doi:10.1530/eje.1.01836)
40. Elder DA, Wooldridge JL, Dolan M & D'Alessio D. Glucose tolerance, insulin secretion and insulin sensitivity in children and adolescents with cystic fibrosis and no prior history of diabetes. Journal of Pediatrics 2007 151 653-658. (doi:10.1016/j.jpeds.2007.05.012)
41. Rakotoambinina B, Delaisi B, Laborde K, Silly C, De Blic J, Lenoir G & Robert JJ. Insulin responses to intravenous glucose and the hyperglycemic clamp in cystic fibrosis patients with different degrees of glucose tolerance. Pediatric Research 1994 36 667-671. (doi:10.1203/00006450-199411000-00024)
42. Hinds A, Sheehan AG & Parsons HG. Tolbutamide causes a modest increase in insulin secretion in cystic fibrosis patients with impaired glucose tolerance. Metabolism 1995 44 13-18. (doi:10.1016/0026-0495(95)90283-X)
43. Holl RW, Heinze E, Wolf A, Rank M & Teller WM. Reduced pancreatic insulin release and reduced peripheral insulin sensitivity contribute to hyperglycaemia in cystic fibrosis. European Journal of Pediatrics 1995 154 356-361. (doi:10.1007/BF02072102)
44. Garagorri JM, Rodríguez G, Ros L & Sánchez A. Early detection of impaired glucose tolerance in patients with cystic fibrosis and predisposition factors. Journal of Pediatric Endocrinology & Metabolism 2001 14 53-60. (doi:10.1515/JPEM.2001.14.1.53)
45. Ripa P, Robertson I, Cowley D, Harris M, Masters IB & Cotterill AM. The relationship between insulin secretion, the insulin-like growth factor axis and growth in children with cystic fibrosis. Clinical Endocrinology 2002 56 383-389. (doi:10.1046/j.1365-2265.2002.01484.x)
46. Mohan K, Miller H, Dyce P, Grainger R, Hughes R, Vora J, Ledson M & Walshaw M. Mechanisms of glucose intolerance in cystic fibrosis. Diabetic Medicine 2009 26 582-588. (doi:10.1111/j.1464-5491.2009.02738.x)
47. Mari A & Ferrannini E. Beta-cell function assessment from modelling of oral tests: an effective approach. Diabetes, Obesity and Metabolism 2008 10 77-87. (doi:10.1111/j.1463-1326.2008.00946.x)
48. Rosenstein BJ & Cutting GR. The diagnosis of cystic fibrosis: a consensus statement cystic fibrosis consensus panel. Journal of Pediatrics 1998 132 589-595. (doi:10.1016/S0022-3476(98)70344-0)
49. Mari A, Pacini G, Murphy E, Ludvik B & Nolan JJ. A model-based method for assessing insulin sensitivity from the oral glucose tolerance test. Diabetes Care 2001 24 539-548. (doi:10.2337/diacare.24.3.539)
50. Mari A, Tura A, Gastaldelli A & Ferrannini E. Assessing insulin secretion by modeling in multiple-meal tests: role of potentiation. Diabetes 2002 51 S221-S226. (doi:10.2337/diabetes.51.2007.S221)
51. Mari A, Schmitz O, Gastaldelli A, Oestergaard T, Nyholm B & Ferrannini E. Meal and oral glucose tests for the assessment of β-cell function: modeling analysis in normal subjects. American Journal of Physiology. Endocrinology and Metabolism 2002 283 E1159-E1166. (doi:10.1152/ajpendo.00093. 2002)
52. Shi ZQ, Giacca A, Fisher SJ, Lekas M, Bilinski D, Van Delangeryt M, Lickley HL & Vranic M. Indirect effects of insulin in regulating glucose fluxes. Advances in Experimental Medicine and Biology 1993 334 151-168. (Pubitemid 23303356)
53. Barron PP, Goobi J, Davies S, Pye S & Radziuk J. Hemipancreatectomy, peripheral diversion of pancreatic venous drain-age, and insulin sensitivity. Transplantation Proceedings 1995 27 3040-3041. (Pubitemid 26016059)
54. Battezzati A, Terruzzi I, Perseghin G, Bianchi E, Di Carlo V, Pozza G & Luzi L. Defective insulin action on protein and glucose metabolism during chronic hyperinsulinaemia in subjects with benign insulinoma. Diabetes 1995 44 837-844. (doi:10.2337/diabetes.44.7.837)
55. Battezzati A, Zerbi A, Perseghin G, Caumo A, Terruzzi I, Di Carlo V & Luzi L. Effect of hemipancreatectomy and of pancreatic diversion on the tolerance to a glucose load in humans. European Journal of Clinical Investigation 2000 30 397-410. (doi:10.1046/j.1365-2362.2000.00648.x)
56. Battezzati A, Mari A, Costantini D, Zazzeron L, Russo C & Colombo C. Contribution of defects in insulin sensitivity and beta-cell function to the changes over time in the glucose tolerance of cystic fibrosis patients. Pediatric Pulmonology 2006 41 391-392. (doi:10.1002/ppul.20400)
57. Olefsky JM & Glass CK. Macrophages, inflammation, and insulin resistance. Annual Review of Physiology 2010 17 219-246. (doi:10.1146/annurev- physiol-021909-135846)
58. Caprio S, Amiel SA, Merkel P & Tamborlane WV. Insulin-resistant syndromes in children. Hormone Research 1993 39 112-114. (doi:10.1159/000182796)
59. de Onis M & Onyango A. The Centers for Disease Control and Prevention 2000 growth charts and the growth of breastfed infants. Acta Paediatrica 2003 92 413-419. (doi:10.1111/j.1651-2227.2003.tb00570.x)